EGFR activation disrupts immunotherapy response via SHP2-mediated suppression of tumor-intrinsic response to IFN-γ. - Zhuang WT; Pang LL; Hu LY; Liao J; Zhan JH; Li T; Chen RX; Zheng JN; Li AL; Yu WY; Mao TQ; Chen L; et al. (The Journal of clinical investigation, 2026)